# Tarsus Pharmaceuticals, Inc.: filings

TARS · Nasdaq · CIK 1819790 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tars.md) · [Financials](/companies/tars/financials.md) · [Filings](/companies/tars/filings.md) · [Insiders](/companies/tars/insiders.md)

## Reports and events: 104 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 303, 144 118, 8-K 70, SC 13G/A 26, 3 24, 10-Q 18, SC 13G 17, SCHEDULE 13G/A 9, 424B5 8, CORRESP 8, S-8 7, UPLOAD 7, 10-K 6, DEF 14A 6, DEFA14A 6, ARS 4, EFFECT 3, S-3ASR 3, DRS/A 2, S-3 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 144/A 1, 3/A 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, DRSLTR 1, FWP 1, S-1 1, S-1/A 1, S-1MEF 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 20:00 ET | [8-K/A](/filings/0001819790-26-000069.md) | 9.01 Financial statements and exhibits | 0001819790-26-000069 |
| 2026-09-10 | 20:05 ET | [8-K](/filings/0001819790-26-000066.md) | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001819790-26-000066 |
| 2026-08-06 | 11:25 ET | [10-Q](/filings/0001819790-26-000064.md) | Quarterly report, period 2026-06-30 | 0001819790-26-000064 |
| 2026-08-06 | 11:23 ET | [8-K](/filings/0001819790-26-000063.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-26-000063 |
| 2026-08-06 | 11:11 ET | [8-K](/filings/0001819790-26-000062.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001819790-26-000062 |
| 2026-08-06 | 11:08 ET | [8-K](/filings/0001819790-26-000060.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001819790-26-000060 |
| 2026-07-13 | 20:11 ET | [8-K](/filings/0001819790-26-000048.md) | 5.02 Departure or appointment of officers or directors | 0001819790-26-000048 |
| 2026-07-08 | 20:13 ET | [8-K](/filings/0001819790-26-000046.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001819790-26-000046 |
| 2026-06-29 | 20:19 ET | [8-K](/filings/0001819790-26-000043.md) | 5.07 Shareholder vote results | 0001819790-26-000043 |
| 2026-05-06 | 20:10 ET | [10-Q](/filings/0001819790-26-000038.md) | Quarterly report, period 2026-03-31 | 0001819790-26-000038 |
| 2026-05-06 | 20:07 ET | [8-K](/filings/0001819790-26-000037.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-26-000037 |
| 2026-04-28 | 20:09 ET | [DEF 14A](/filings/0001819790-26-000028.md) | Proxy statement, period 2026-06-25 | 0001819790-26-000028 |
| 2026-02-23 | 21:11 ET | [10-K](/filings/0001819790-26-000019.md) | Annual report, period 2025-12-31 | 0001819790-26-000019 |
| 2026-02-23 | 21:07 ET | [8-K](/filings/0001819790-26-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-26-000017 |
| 2026-02-18 | 13:32 ET | [8-K](/filings/0001819790-26-000005.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001819790-26-000005 |
| 2026-01-12 | 13:41 ET | [8-K](/filings/0001819790-26-000002.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001819790-26-000002 |
| 2025-11-04 | 21:10 ET | [10-Q](/filings/0001819790-25-000121.md) | Quarterly report, period 2025-09-30 | 0001819790-25-000121 |
| 2025-11-04 | 21:08 ET | [8-K](/filings/0001819790-25-000120.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-25-000120 |
| 2025-08-06 | 20:10 ET | [10-Q](/filings/0001819790-25-000108.md) | Quarterly report, period 2025-06-30 | 0001819790-25-000108 |
| 2025-08-06 | 20:08 ET | [8-K](/filings/0001819790-25-000107.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-25-000107 |
| 2025-06-18 | 20:05 ET | [8-K](/filings/0001819790-25-000100.md) | 5.07 Shareholder vote results | 0001819790-25-000100 |
| 2025-05-01 | 20:10 ET | [10-Q](/filings/0001819790-25-000078.md) | Quarterly report, period 2025-03-31 | 0001819790-25-000078 |
| 2025-05-01 | 20:07 ET | [8-K](/filings/0001819790-25-000077.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-25-000077 |
| 2025-04-28 | 20:04 ET | [DEF 14A](/filings/0001819790-25-000070.md) | Proxy statement, period 2025-06-12 | 0001819790-25-000070 |
| 2025-03-18 | 20:01 ET | [8-K](/filings/0001819790-25-000035.md) | 8.01 Other events | 0001819790-25-000035 |
| 2025-03-13 | 20:40 ET | [8-K](/filings/0001193125-25-053978.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-053978 |
| 2025-02-25 | 21:03 ET | [10-K](/filings/0001819790-25-000011.md) | Annual report, period 2024-12-31 | 0001819790-25-000011 |
| 2025-02-25 | 12:07 ET | [8-K](/filings/0001819790-25-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-25-000007 |
| 2025-01-17 | 22:08 ET | [8-K](/filings/0001819790-25-000003.md) | 5.02 Departure or appointment of officers or directors | 0001819790-25-000003 |
| 2025-01-13 | 13:30 ET | [8-K](/filings/0001193125-25-005030.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005030 |
| 2024-12-19 | 22:03 ET | [8-K](/filings/0001819790-24-000138.md) | 1.01 Entry into a material agreement | 0001819790-24-000138 |
| 2024-11-13 | 21:12 ET | [10-Q](/filings/0001819790-24-000129.md) | Quarterly report, period 2024-09-30 | 0001819790-24-000129 |
| 2024-11-13 | 21:06 ET | [8-K](/filings/0001819790-24-000127.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-24-000127 |
| 2024-11-05 | 21:06 ET | [8-K](/filings/0001819790-24-000119.md) | 5.02 Departure or appointment of officers or directors | 0001819790-24-000119 |
| 2024-08-08 | 20:13 ET | [10-Q](/filings/0001819790-24-000111.md) | Quarterly report, period 2024-06-30 | 0001819790-24-000111 |
| 2024-08-08 | 20:07 ET | [8-K](/filings/0001819790-24-000109.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-24-000109 |
| 2024-06-18 | 20:26 ET | [8-K](/filings/0001819790-24-000087.md) | 5.07 Shareholder vote results | 0001819790-24-000087 |
| 2024-05-08 | 20:12 ET | [10-Q](/filings/0001819790-24-000063.md) | Quarterly report, period 2024-03-31 | 0001819790-24-000063 |
| 2024-05-08 | 20:09 ET | [8-K](/filings/0001819790-24-000062.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-24-000062 |
| 2024-04-26 | 20:24 ET | [DEF 14A](/filings/0001819790-24-000056.md) | Proxy statement, period 2024-06-13 | 0001819790-24-000056 |
| 2024-04-23 | 12:34 ET | [8-K](/filings/0001819790-24-000050.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001819790-24-000050 |
| 2024-03-05 | 21:09 ET | [8-K](/filings/0001819790-24-000024.md) | 8.01 Other events | 0001819790-24-000024 |
| 2024-03-01 | 22:26 ET | [8-K](/filings/0001193125-24-056209.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-056209 |
| 2024-02-27 | 21:02 ET | [10-K](/filings/0001819790-24-000018.md) | Annual report, period 2023-12-31 | 0001819790-24-000018 |
| 2024-02-27 | 02:18 ET | [8-K](/filings/0001819790-24-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-24-000015 |
| 2024-01-18 | 21:30 ET | [8-K](/filings/0001819790-24-000006.md) | 5.02 Departure or appointment of officers or directors | 0001819790-24-000006 |
| 2024-01-08 | 14:00 ET | [8-K](/filings/0001819790-24-000004.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001819790-24-000004 |
| 2023-12-11 | 14:01 ET | [8-K](/filings/0001819790-23-000088.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001819790-23-000088 |
| 2023-11-09 | 21:05 ET | [8-K](/filings/0001819790-23-000081.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819790-23-000081 |
| 2023-11-09 | 21:00 ET | [10-Q](/filings/0001819790-23-000080.md) | Quarterly report, period 2023-09-30 | 0001819790-23-000080 |

Page 1 of 3. [Older](/companies/tars/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.